New solution reduces requirements gathering timelines from months to days while capturing expert-level institutional ...
With evaluation failures and payout issues on the rise, CTI urges firms to adopt fairer, more transparent practices. CTI's stance follows a growing wave of concern from traders and regulators. Recent ...
Swedish Orphan Biovitrum AB, or Sobi, SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. CTIC in a deal valued at $1.7 billion. Shares of ...
CTI BioPharma has one FDA-approved therapy, Vonjo, to treat a rare form of bone marrow cancer. The company is being bought at a 89% premium from its closing price on Tuesday. CTI will become a wholly ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min With the deal, Seattle-based CTI ...